I agree that this site is using cookies. You can find further informations here.
X
Wranke, A.
54  results:
Search for persons X
?
1

Die interdisziplinäre alterstraumatologische Visite: Empfeh..:

Heck, J. ; Ranker, A. ; Wranke, A....
Der Unfallchirurg.  124 (2020)  2 - p. 138-145 , 2020
Link: https://doi.org/10.1007/..
 
?
2

Treating chronic hepatitis delta: The need for surrogate ma..:

Yurdaydin, Cihan ; Abbas, Zaigham ; Buti, Maria...
Journal of Hepatology.  70 (2019)  5 - p. 1008-1015 , 2019
Link: https://doi.org/10.1016/..
 
?
3

Long-term outcome of hepatitis delta compared to HBV monoin..:

Wranke, A. ; Deterding, K. ; Heidrich, B....
Journal of Hepatology.  68 (2018)  - p. S489-S490 , 2018
Link: https://doi.org/10.1016/..
 
?
4

Viral dominance patterns in chronic hepatitis delta determi..:

Lutterkort, G. L. ; Wranke, A. ; Hengst, J....
Journal of Viral Hepatitis.  25 (2018)  11 - p. 1384-1394 , 2018
Link: https://doi.org/10.1111/..
 
?
5

A virological response to PEG-IFNa treatment of hepatitis d..:

Wranke, A. ; Yurdaydin, C. ; Heidrich, B....
Journal of Hepatology.  68 (2018)  - p. S507 , 2018
Link: https://doi.org/10.1016/..
 
?
6

Risk factors and seroprevalence of hepatitis E evaluated in..:

Hardtke, S. ; Rocco, R. ; Ogata, J....
Journal of Medical Virology.  90 (2018)  12 - p. 1856-1862 , 2018
Link: https://doi.org/10.1002/..
 
?
7

Interferon-free therapy of chronic hepatitis C does not cha..:

Mettke, F. ; Schlevogt, B. ; Deterding, K....
Journal of Hepatology.  66 (2017)  1 - p. S210-S211 , 2017
Link: https://doi.org/10.1016/..
 
?
8

Interferon‐free therapy of chronic hepatitis C with direct‐..:

Mettke, F. ; Schlevogt, B. ; Deterding, K....
Alimentary Pharmacology & Therapeutics.  47 (2017)  4 - p. 516-525 , 2017
Link: https://doi.org/10.1111/..
 
?
9

Whole genome deep sequencing is superior to sequencing only..:

Wellhöner, F. ; Wranke, A. ; Barrantes, I....
Journal of Hepatology.  66 (2017)  1 - p. S485 , 2017
Link: https://doi.org/10.1016/..
 
?
10

Diversity of clinical presentation and virological characte..:

Wranke, A. ; Hardtke, S. ; Borzacov, L.M.P....
Journal of Hepatology.  66 (2017)  1 - p. S257-S258 , 2017
Link: https://doi.org/10.1016/..
 
?
11

A phase 2 dose-escalation study of lonafarnib plus ritonavi..:

Wedemeyer, H. ; Port, K. ; Deterding, K....
Journal of Hepatology.  66 (2017)  1 - p. S24 , 2017
Link: https://doi.org/10.1016/..
 
?
12

Non-Invasive Clinical Scores to Identify Liver Fibrosis in ..:

Lutterkort, G.L. ; Wranke, A. ; Yurdaydin, C....
Journal of Hepatology.  64 (2016)  2 - p. S361 , 2016
Link: https://doi.org/10.1016/..
 
?
13

Does Antiviral Treatment Affect the Clinical Long-Term Outc..:

Wranke, A. ; Serrano, B.C. ; Heidrich, B....
Journal of Hepatology.  64 (2016)  2 - p. S163-S164 , 2016
Link: https://doi.org/10.1016/..
 
?
14

P0638 : Global epidemiology of hepatitis delta: First data ..:

Hardtke, S. ; Abbas, Z. ; Hamid, S....
Journal of Hepatology.  62 (2015)  - p. S558 , 2015
Link: https://doi.org/10.1016/..
 
?
15

Current Management of HBV/HDV Coinfection and Future Perspe..:

Wranke, A. ; Heidrich, B. ; Hardtke, S..
Current Hepatology Reports.  14 (2015)  4 - p. 284-292 , 2015
Link: https://doi.org/10.1007/..
 
1-15